What is the most likely diagnosis for a soft‑tissue swelling of the medial first metatarsophalangeal joint with an amorphous calcific density?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Likely Diagnosis: Acute Calcific Periarthritis (Hydroxyapatite Pseudopodagra)

The presentation of soft tissue swelling at the medial first metatarsophalangeal (MTP) joint with amorphous calcification is most consistent with acute calcific periarthritis (ACP), also known as hydroxyapatite pseudopodagra, caused by basic calcium phosphate deposition (BCPD).

Diagnostic Reasoning

The first MTP joint is a disease-specific target site for gout 1, making this location critical for distinguishing between crystal-induced arthropathies. However, the key distinguishing feature here is the amorphous calcific density, which is characteristic of hydroxyapatite (basic calcium phosphate) deposition rather than monosodium urate crystals.

Why This is ACP/Hydroxyapatite Pseudopodagra:

  • Amorphous calcification on imaging is the hallmark finding of ACP at the first MTP joint 2, 3
  • The periarticular location (medial aspect) is typical for this condition 2
  • This presentation classically mimics gout (hence "pseudopodagra") but represents BCPD rather than monosodium urate deposition 3, 4
  • Predominantly affects young to middle-aged women, though can occur in men 4

Key Differentiating Features from Gout:

While gout commonly affects the first MTP joint, the amorphous calcification pattern is not typical for gout. Gout produces:

  • Monosodium urate crystal deposits (not amorphous calcium)
  • Tophi (soft tissue masses) or double-contour sign on ultrasound 1
  • Erosions with overhanging edges in chronic disease

Diagnostic Approach

For BCPD diagnosis, imaging is necessary; conventional radiography or ultrasound is the recommended modality 1. In your case, the plain radiograph has already revealed the diagnostic amorphous calcification.

Next Steps:

  1. Clinical correlation: Look for acute onset pain, swelling, erythema, and tenderness that developed rapidly 2, 3

  2. Laboratory evaluation: Check inflammatory markers and serum uric acid, but expect them to be normal or only mildly elevated 5

  3. Joint aspiration (if diagnostic uncertainty remains):

    • Should be negative for monosodium urate and calcium pyrophosphate crystals 2
    • May show hydroxyapatite crystals (though these are difficult to identify on standard microscopy)
    • Ultrasound guidance recommended if aspiration is challenging 1

Important Caveat:

Do not mistake this for septic arthritis or cellulitis 3. The clinical presentation can be dramatic with erythema and swelling, but if inflammatory markers are normal/mildly elevated and imaging shows characteristic calcification, infection is unlikely. Unnecessary antibiotics or surgical drainage should be avoided 5, 3.

Management Implications

This diagnosis is critical because ACP is self-limiting and responds well to conservative management 5, 2:

  • Corticosteroid injection provides rapid symptom relief with complete resolution typically within 2 weeks 5, 2
  • Ultrasound-guided barbotage (aspiration and lavage) can be performed if calcific deposits are large 5
  • No antibiotics or surgical intervention needed 5
  • The calcifications may disappear spontaneously over time 3

Serial imaging is not recommended unless there is unexpected change in clinical characteristics 1, as this condition resolves with treatment.

Related Questions

What is the clinical significance and recommended management of amorphous calcification in the metatarsophalangeal (MTP) joint?
What is the recommended management for amorphous calcification with mild degenerative changes at the metatarsophalangeal (MTP) joint?
What is the differential diagnosis for a 26-year-old woman presenting with three weeks of wrist, metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joint pain, prolonged morning stiffness, mild joint swelling, erythematous facial rash, low-grade fever, foamy urine, and bilateral lower-extremity edema?
What is the differential diagnosis for metacarpophalangeal (MCP) joint pain of the index finger?
In a 30-year-old man with a one-week history of left second metacarpophalangeal joint monoarthritis after a gout flare, CT shows erosions of the second metacarpal head, soft‑tissue swelling, joint effusion, periosteal reaction, and an old cortical irregularity of the fifth metacarpal—what is the most likely diagnosis, should MRI be obtained, and is orthopaedic referral indicated?
What are examples of Mendelian autosomal dominant disorders?
What is the effectiveness of methadone maintenance therapy in reducing maternal mortality and illicit opioid use among pregnant and postpartum women with opioid use disorder?
Given a hemoglobin of 7.8 g/dL, hematocrit of 28.8 %, total iron of 17 µg/dL, and ferritin of 3 ng/mL, should the patient be taken to the emergency department for urgent evaluation?
What is insulin‑autoimmune syndrome (Hirata disease)?
What is the clinical significance of a C-reactive protein (CRP) level of 1.8 mg/L in an adult?
What are the adult dosing guidelines, contraindications, and safety considerations for erdosteine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.